Revolutionary Blood Test Spots Brain Cancer

Scientists have made significant strides toward a blood test capable of detecting brain tumors with over 90% accuracy. This innovative approach aims to streamline the diagnostic process, which currently relies on complex methods like MRI scans and invasive biopsies. Researchers at the University of Manchester, with international collaborators, have identified a pair of proteins in the blood that can accurately signal the presence of tumors.

Initially focusing on fast-growing glioblastomas, the research is expanding to cover other types of brain tumors. Lead researcher Prof. Petra Hamerlik highlighted the devastating nature of glioblastoma and the historical barrier of unreliable diagnostic tests. The team's goal is to develop a user-friendly device, similar to a COVID-19 test, that could be integrated into the NHS within a decade.

Dr. Simon Newman of the Brain Tumour Charity emphasized the critical need for early and accurate diagnosis, noting the limitations of existing tools. A clinical trial is currently underway at six sites in the UK and four internationally, evaluating the test's efficacy in real-world scenarios. This development marks a crucial step towards simpler, non-invasive monitoring of brain tumor response to treatment.